Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Gov't & Regulatory

EQRx Retracts Promise to Bring Low-Cost China Drugs to US
China Blocks GSK Generic BPH Drug Due to Safety Concerns
US Blocks Asymchem’s $58 Million Acquisition of Boston’s Snapdragon
WSJ Says China and US are Close to Agreement on Auditing Standoff
Shanghai Zai Lab Raises Hong Kong Listing to Primary Status
ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China